Literature DB >> 32747591

Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection.

Diego Lara1,2, Thomas Young1,2, Kamill Del Toro1, Victor Chan2, Cora Ianiro2, Kenneth Hunt2, Jake Kleinmahon3,2.   

Abstract

The majority of patients with coronavirus disease 2019 (COVID-19) display pulmonary disease; however, a significant portion of patients have cardiac injury as well, with a high incidence of myocarditis documented in the adult population. Pediatric disease from COVID-19 has been relatively rare, and no cases of virus-related cardiac disease have been published. We present a case of an adolescent girl with fulminant myocarditis with complete heart block, elevated troponin I levels, and severely depressed systolic function in the setting of COVID-19 infection.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 32747591     DOI: 10.1542/peds.2020-1509

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

Review 1.  Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children.

Authors:  Eric J Chow; Janet A Englund
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

Review 2.  Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.

Authors:  Sarah Cushion; Vania Arboleda; Yousef Hasanain; Michelle Demory Beckler; Patrick Hardigan; Marc M Kesselman
Journal:  Cureus       Date:  2022-04-12

3.  Cardiovascular impact of COVID-19 with a focus on children: A systematic review.

Authors:  Moises Rodriguez-Gonzalez; Ana Castellano-Martinez; Helena Maria Cascales-Poyatos; Alvaro Antonio Perez-Reviriego
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

4.  SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study.

Authors:  Guillaume Gauchotte; Véronique Venard; Michaël Segondy; Cyril Cadoz; Aude Esposito-Fava; Damien Barraud; Guillaume Louis
Journal:  Int J Legal Med       Date:  2021-01-03       Impact factor: 2.686

Review 5.  The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury.

Authors:  Bhurint Siripanthong; Babken Asatryan; Thomas C Hanff; Salman R Chatha; Mohammed Y Khanji; Fabrizio Ricci; Daniele Muser; Victor A Ferrari; Saman Nazarian; Pasquale Santangeli; Rajat Deo; Leslie T Cooper; Saidi A Mohiddin; C Anwar A Chahal
Journal:  JACC Basic Transl Sci       Date:  2022-02-09

Review 6.  Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination.

Authors:  Stephanie E Chin; Sejal M Bhavsar; Andrew Corson; Zelda J Ghersin; Hannah S Kim
Journal:  Pediatr Cardiol       Date:  2022-03-08       Impact factor: 1.655

Review 7.  SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.

Authors:  Adam L Dorfman; Tal Geva; Margaret M Samyn; Gerald Greil; Rajesh Krishnamurthy; Daniel Messroghli; Pierluigi Festa; Aurelio Secinaro; Brian Soriano; Andrew Taylor; Michael D Taylor; René M Botnar; Wyman W Lai
Journal:  J Cardiovasc Magn Reson       Date:  2022-07-21       Impact factor: 6.903

8.  Community-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review.

Authors:  Elyse G Mark; W Christopher Golden; Maureen M Gilmore; Anna Sick-Samuels; Melanie S Curless; Lawrence M Nogee; Aaron M Milstone; Julia Johnson
Journal:  J Pediatr       Date:  2020-09-08       Impact factor: 4.406

Review 9.  SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.

Authors:  Ossama K Abou Hassan; Calvin C Sheng; Tom Kai Ming Wang; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2021-08-03       Impact factor: 2.931

10.  Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report.

Authors:  Kelsey McLean; Tiffani J Johnson
Journal:  Acad Emerg Med       Date:  2021-07-21       Impact factor: 3.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.